TSX:VMD

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Viemed Healthcare

Executive Summary

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States.


Snowflake Analysis

Excellent balance sheet with acceptable track record.

Share Price & News

How has Viemed Healthcare's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: VMD's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

9.1%

VMD

1.6%

CA Healthcare

1.6%

CA Market


1 Year Return

19.9%

VMD

-28.1%

CA Healthcare

-14.5%

CA Market

Return vs Industry: VMD exceeded the Canadian Healthcare industry which returned -28.1% over the past year.

Return vs Market: VMD exceeded the Canadian Market which returned -14.5% over the past year.


Shareholder returns

VMDIndustryMarket
7 Day9.1%1.6%1.6%
30 Day24.5%8.3%3.6%
90 Day82.2%-6.2%-15.0%
1 Year19.9%19.9%-26.0%-28.1%-11.5%-14.5%
3 Yearn/a-43.7%-50.8%-2.2%-11.3%
5 Yearn/a-17.7%-36.2%11.8%-4.4%

Price Volatility Vs. Market

How volatile is Viemed Healthcare's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Viemed Healthcare undervalued compared to its fair value and its price relative to the market?

29.37x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: VMD (CA$11.75) is trading above our estimate of fair value (CA$2.15)

Significantly Below Fair Value: VMD is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: VMD is poor value based on its PE Ratio (29.4x) compared to the Healthcare industry average (29.3x).

PE vs Market: VMD is poor value based on its PE Ratio (29.4x) compared to the Canadian market (13.1x).


Price to Earnings Growth Ratio

PEG Ratio: VMD is poor value based on its PEG Ratio (3.9x)


Price to Book Ratio

PB vs Industry: VMD is overvalued based on its PB Ratio (6.6x) compared to the CA Healthcare industry average (2.5x).


Next Steps

Future Growth

How is Viemed Healthcare forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

7.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: VMD's forecast earnings growth (7.6% per year) is above the savings rate (1.7%).

Earnings vs Market: VMD's earnings (7.6% per year) are forecast to grow slower than the Canadian market (21.1% per year).

High Growth Earnings: VMD's earnings are forecast to grow, but not significantly.

Revenue vs Market: VMD's revenue (10% per year) is forecast to grow faster than the Canadian market (5.5% per year).

High Growth Revenue: VMD's revenue (10% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VMD's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Viemed Healthcare performed over the past 5 years?

7.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: VMD has a high level of non-cash earnings.

Growing Profit Margin: VMD's current net profit margins (12.6%) are lower than last year (13.3%).


Past Earnings Growth Analysis

Earnings Trend: VMD's earnings have grown by 7.8% per year over the past 5 years.

Accelerating Growth: VMD's earnings growth over the past year (18.5%) exceeds its 5-year average (7.8% per year).

Earnings vs Industry: VMD earnings growth over the past year (18.5%) underperformed the Healthcare industry 18.5%.


Return on Equity

High ROE: VMD's Return on Equity (22.2%) is considered high.


Next Steps

Financial Health

How is Viemed Healthcare's financial position?


Financial Position Analysis

Short Term Liabilities: VMD's short term assets ($30.2M) exceed its short term liabilities ($26.1M).

Long Term Liabilities: VMD's short term assets ($30.2M) exceed its long term liabilities ($11.9M).


Debt to Equity History and Analysis

Debt Level: VMD's debt to equity ratio (19.4%) is considered satisfactory.

Reducing Debt: VMD's debt to equity ratio has increased from 10.7% to 19.4% over the past 5 years.

Debt Coverage: VMD's debt is well covered by operating cash flow (201.5%).

Interest Coverage: VMD's interest payments on its debt are well covered by EBIT (22.8x coverage).


Balance Sheet


Next Steps

Dividend

What is Viemed Healthcare's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate VMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate VMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if VMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if VMD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of VMD's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.2yrs

Average management tenure


CEO

Casey Hoyt (42yo)

2.42yrs

Tenure

US$2,167,644

Compensation

Mr. Casey Hoyt has been Director of Viemed Healthcare, Inc. since December 14, 2016 and serves as Chief Executive Officer. Mr. Hoyt served as Chief Executive Officer of Patient Home Monitoring Corp. from  ...


CEO Compensation Analysis

Compensation vs Market: Casey's total compensation ($USD2.17M) is above average for companies of similar size in the Canadian market ($USD1.20M).

Compensation vs Earnings: Casey's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Casey Hoyt
CEO & Director2.42yrsUS$2.17m5.39% $24.4m
Michael Moore
President2.42yrsUS$1.73m5.18% $23.4m
Trae Fitzgerald
Chief Financial Officer2.42yrsUS$677.33k0.089% $404.6k
William Zehnder
COO & Director2.42yrsUS$1.68m0.30% $1.3m
Jerome Cambre
Vice President of Sales2.17yrsUS$657.93k0.11% $488.6k
William Frazier
Chief Medical Officer & Director2.42yrsno data0.049% $223.8k
John Collier
Chief Technology Officer0.42yrno datano data
Claudio Munoz
Chief Information Officer0.42yrno datano data
Brett Stoute
Chief Compliance Officerno datano datano data
Rob Birkhead
Chief Marketing Officer0.42yrno datano data

2.2yrs

Average Tenure

43yo

Average Age

Experienced Management: VMD's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Casey Hoyt
CEO & Director2.42yrsUS$2.17m5.39% $24.4m
William Zehnder
COO & Director2.42yrsUS$1.68m0.30% $1.3m
William Frazier
Chief Medical Officer & Director2.42yrsno data0.049% $223.8k
Randolph Dobbs
Independent Chairman2.42yrsUS$162.93k0.11% $494.0k
Nitin Kaushal
Independent Director2.42yrsUS$162.93k0.18% $813.5k
Timothy Smokoff
Independent Director2.33yrsUS$162.93k0.088% $400.0k
Bruce Greenstein
Independent Director1.83yrsUS$162.93k0.049% $223.8k

2.4yrs

Average Tenure

53yo

Average Age

Experienced Board: VMD's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 2.1%.


Top Shareholders

Company Information

Viemed Healthcare, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Viemed Healthcare, Inc.
  • Ticker: VMD
  • Exchange: TSX
  • Founded: 2006
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$452.220m
  • Shares outstanding: 38.49m
  • Website: https://www.viemed.com

Number of Employees


Location

  • Viemed Healthcare, Inc.
  • 625 East Kaliste Saloom Road
  • Lafayette
  • Louisiana
  • 70508
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
VMDTSX (The Toronto Stock Exchange)YesCommon SharesCACADDec 2017
VMDNasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDDec 2017
VIJDB (Deutsche Boerse AG)YesCommon SharesDEEURDec 2017

Biography

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen units, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/05/26 09:20
End of Day Share Price2020/05/25 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.